XLMM
2022-04-06

$Novavax(NVAX)$3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street


Novavax: Implied upside of 257%

The first COVID-19 play that offers drool-worthy upside, at least according to one Wall Street analyst, is biotech stock Novavax ( NVAX -13.36% ). Despite a $50 price-target reduction in February, B. Riley analyst Mayank Mamtani still believes Novavax can reach $265 a share. This represents a cool 257% upside from where shares ended last week.

Mamtani's aggressive price target is based on a few factors. For instance, he believes that concerns over Novavax's near-term manufacturing struggles are overblown. Mamtani explained months ago that Novavax was nearing its monthly manufacturing target of around 150 million doses, and would likely be exporting more than 100 million monthly doses out of India, where it's working with the Serum Institute of India to produce NVX-CoV2373 vaccines. 


https://www.fool.com/investing/2022/04/06/3-covid-19-stocks-monster-upside-355-wall-street/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Frosty4ever
    2022-04-07
    Frosty4ever
    hoping the bleeding stops.
    • XLMM
      Yes, i hope so too.. well, i am adding more 😉
  • Maria_yy
    2022-04-06
    Maria_yy
    Can Novavax surge this year?
    • Maria_yyReplyXLMM
      Let's see how it does.
    • XLMM
      Hoping it does, there are opportunities for it to surge...
  • EvanHolt
    2022-04-06
    EvanHolt
    Vaccine stocks have been the darling of financial markets for two years.
  • Michane
    2022-04-06
    Michane
    still waiting for this to surge [lovely]
  • LouisLowell
    2022-04-06
    LouisLowell
    Doubling Novavax shouldn't be a problem.
  • LWayne
    2022-04-07
    LWayne
    really?
Leave a comment